Technical Analysis for PRVB - Provention Bio, Inc.

Grade Last Price % Change Price Change
grade C 3.36 0.30% 0.01
PRVB closed up 0.3 percent on Wednesday, April 24, 2019, on 1.66 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Up Up
See historical PRVB trend table...

Date Alert Name Type % Chg
Doji - Bearish? Reversal 0.00%
Upper Bollinger Band Walk Strength 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Upper Bollinger Band Walk Strength 0.30%
Wide Bands Range Expansion 0.30%
Above Upper BB Strength 0.30%
Overbought Stochastic Strength 0.30%
Upper Bollinger Band Touch Strength 0.30%

Older signals for PRVB ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Provention Bio, Inc. is a clinical-stage biopharmaceutical company that develops therapeutics targeting immune-mediated diseases. The Company aims at developing therapies for disease that include type one diabetes (T1D), Crohn’s disease, ulcerative colitis, lupus and other viral diseases. The Company’s principal product candidates include PRV-031, PRV-6527, PRV-300, PRV-3279, and PRV-0101.PRV-031 is a product candidate in its Phase III clinical trial that is developed for the interception of T1D. PRV-6527 is an oral CSF-1R inhibitor for the treatment of Crohn’s disease. PRV-300 is developed for the treatment of ulcerative colitis. PRV-3279 is developed to treat lupus disease. PRV-101 is a multivalent coxsackie virus (CVB) vaccine for the prevention of acute CVB and the prevention of the onset of T1D.
Medicine Biopharmaceutical Medical Specialties Immunology Disease Diabetes Autoimmune Diseases Ulcerative Colitis Abdominal Pain Diarrhea Crohn's Disease Viral Diseases Colitis Lupus Immune Mediated Diseases
Is PRVB a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 8.0
52 Week Low 1.52
Average Volume 42,993
200-Day Moving Average 0.0
50-Day Moving Average 2.5083
20-Day Moving Average 2.707
10-Day Moving Average 3.013
Average True Range 0.2194
ADX 43.29
+DI 33.5483
-DI 6.5651
Chandelier Exit (Long, 3 ATRs ) 2.7918
Chandelier Exit (Short, 3 ATRs ) 2.8582
Upper Bollinger Band 3.4322
Lower Bollinger Band 1.9818
Percent B (%b) 0.95
BandWidth 53.579608
MACD Line 0.2331
MACD Signal Line 0.1571
MACD Histogram 0.076
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.66
Resistance 3 (R3) 3.66 3.55 3.61
Resistance 2 (R2) 3.55 3.48 3.56 3.59
Resistance 1 (R1) 3.46 3.43 3.51 3.46 3.58
Pivot Point 3.35 3.35 3.38 3.36 3.35
Support 1 (S1) 3.26 3.28 3.31 3.26 3.14
Support 2 (S2) 3.15 3.23 3.16 3.13
Support 3 (S3) 3.06 3.15 3.11
Support 4 (S4) 3.06